PORADOSU ENRIQUE (Chief Science and Business Off) purchased 0.0% of their position (500.00 shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $5.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/28/2023ACC: 0001104659-23-037421
Officer· Chief Science and Business Off
Since Feb 2022
+500.00
Net shares
Net buyer
$5.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
500.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+500.00
Price / share
$11.55
Trade value
$5.78K
% of position
0.0%
3/27/2023
1.37M→1.37M
Total
Net shares
+500.00
Net value
$5.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2023 | P · Purchase | +500.00 | $11.55 | $5.78K | 0.0% | 1.37M | 1.37M |
| Total | +500.00 | $5.78K | ||||||
Derivative Transactions0
No derivative transactions reported